医学
单克隆抗体
发病机制
单克隆
肾病
免疫学
抗体
免疫球蛋白A
癌症研究
内分泌学
糖尿病
免疫球蛋白G
作者
Mohit Mathur,Jonathan Barratt,Bobby Chacko,Tak Mao Chan,Laura Kooienga,Kook‐Hwan Oh,Manisha Sahay,Yusuke Suzuki,Muh Geot Wong,Jill Yarbrough,Jing Xia,Brian J.G. Pereira
标识
DOI:10.1056/nejmoa2305635
摘要
In patients with IgA nephropathy, 12 months of treatment with sibeprenlimab resulted in a significantly greater decrease in proteinuria than placebo. (Funded by Visterra; ENVISION ClinicalTrials.gov number, NCT04287985; EudraCT number, 2019-002531-29.).
科研通智能强力驱动
Strongly Powered by AbleSci AI